Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:40 pm
| PEG Ratio | -3.17 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fairchem Organics Ltd operates in the organic chemicals sector, with a market capitalization of ₹977 Cr and a current share price of ₹750. The company has experienced fluctuations in revenue, with sales recorded at ₹648 Cr in FY 2023, slightly declining to ₹621 Cr in FY 2024, and further projected to be ₹538 Cr for FY 2025. The trailing twelve months (TTM) sales stood at ₹504 Cr, indicating a downward trend. Quarterly sales showed variability, peaking at ₹225.12 Cr in Jun 2022 but declining to ₹148.11 Cr by Dec 2023. This volatility highlights challenges in maintaining consistent revenue streams, which may stem from market dynamics or operational inefficiencies. The overall sales performance suggests the need for strategic repositioning to stabilize revenue and enhance growth in a competitive environment.
Profitability and Efficiency Metrics
Fairchem’s profitability metrics reveal a concerning trend, with an operating profit margin (OPM) of just 3.99%, significantly lower than the sector average. The company reported an operating profit of ₹72 Cr in FY 2023, declining to ₹67 Cr in FY 2024, and further down to ₹43 Cr in FY 2025. The net profit for FY 2023 was ₹44 Cr, which dropped to ₹40 Cr in FY 2024 and is expected to decline to ₹22 Cr in FY 2025. Return on equity (ROE) stood at 7.51%, while return on capital employed (ROCE) was at 10.2%, both indicating subpar performance against industry benchmarks. The cash conversion cycle has increased to 137 days in FY 2025, reflecting inefficiencies in working capital management, which could hinder operational agility and profitability.
Balance Sheet Strength and Financial Ratios
Fairchem Organics Ltd’s balance sheet reflects a mixed financial health profile. The company has total borrowings of ₹63 Cr against reserves of ₹289 Cr, indicating a manageable debt level. The current ratio is reported at 2.30, suggesting adequate liquidity to cover short-term obligations. However, the interest coverage ratio (ICR) of 12.03x is relatively robust, allowing for comfortable servicing of debt. The price-to-book value (P/BV) ratio stood at 3.78x, indicating a premium valuation in comparison to its book value of ₹231.96 per share. However, the decline in net profit margins to 4.08% in FY 2025 raises concerns about the sustainability of profitability amidst rising costs and competitive pressures. Overall, while the balance sheet shows some strengths, the declining profitability metrics warrant close attention.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fairchem Organics Ltd indicates a stable ownership structure, with promoters holding 61.20% as of Mar 2025. This significant promoter stake suggests strong management commitment, which can foster investor confidence. Foreign Institutional Investors (FIIs) hold 6.18%, while Domestic Institutional Investors (DIIs) account for 5.77%, indicating modest institutional interest. The public shareholding stood at 26.86%, reflecting a broad base of retail investors. However, the number of shareholders has decreased from 32,869 in Dec 2022 to 28,990 by Mar 2025, which may indicate waning investor confidence amid declining financial performance. The consistent dividend payout, although reduced to ₹7.50 per share in FY 2025, underscores a commitment to returning value to shareholders despite profitability challenges.
Outlook, Risks, and Final Insight
Looking ahead, Fairchem Organics Ltd faces several risks that could impact its performance, including declining revenue trends and profitability pressures, which could affect investor sentiment and stock performance. Additionally, the increasing cash conversion cycle highlights operational inefficiencies that may hinder growth. However, the strong promoter backing and manageable debt levels provide a foundation for potential recovery. If the company can effectively address its operational challenges and stabilize revenue, it could regain investor confidence and improve financial performance. On the other hand, failure to navigate these challenges may lead to further declines in profitability and market valuation. Overall, the company’s future hinges on strategic initiatives aimed at enhancing operational efficiency and revenue generation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fairchem Organics Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 124 Cr. | 348 | 458/255 | 128 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,648 Cr. | 9,648 | 14,284/8,150 | 57.5 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 37.9 Cr. | 126 | 329/114 | 15.3 | 24.9 | 0.79 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 260 Cr. | 325 | 385/160 | 20.1 | 94.6 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,428.00 Cr | 1,667.80 | 402.50 | 327.18 | 0.36% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 225.12 | 168.54 | 102.48 | 151.90 | 160.59 | 152.21 | 148.11 | 160.56 | 164.93 | 138.62 | 113.57 | 120.78 | 131.06 |
| Expenses | 185.05 | 159.22 | 98.81 | 132.66 | 148.96 | 135.38 | 128.36 | 141.79 | 143.16 | 129.86 | 105.74 | 116.36 | 125.83 |
| Operating Profit | 40.07 | 9.32 | 3.67 | 19.24 | 11.63 | 16.83 | 19.75 | 18.77 | 21.77 | 8.76 | 7.83 | 4.42 | 5.23 |
| OPM % | 17.80% | 5.53% | 3.58% | 12.67% | 7.24% | 11.06% | 13.33% | 11.69% | 13.20% | 6.32% | 6.89% | 3.66% | 3.99% |
| Other Income | 0.28 | 0.00 | 0.27 | 0.17 | 0.15 | 0.46 | 0.25 | 0.28 | 0.24 | 0.38 | 0.48 | 0.24 | 0.13 |
| Interest | 2.41 | 1.62 | 0.92 | 1.32 | 1.35 | 1.30 | 0.97 | 0.62 | 0.81 | 1.02 | 0.93 | 0.91 | 1.01 |
| Depreciation | 1.89 | 2.05 | 2.09 | 2.13 | 2.15 | 2.18 | 2.40 | 2.55 | 2.59 | 2.64 | 2.67 | 2.64 | 2.74 |
| Profit before tax | 36.05 | 5.65 | 0.93 | 15.96 | 8.28 | 13.81 | 16.63 | 15.88 | 18.61 | 5.48 | 4.71 | 1.11 | 1.61 |
| Tax % | 25.02% | 29.20% | 35.48% | 25.69% | 25.97% | 25.56% | 25.86% | 25.88% | 25.63% | 26.82% | 25.48% | 46.85% | 27.33% |
| Net Profit | 27.03 | 4.00 | 0.61 | 11.86 | 6.12 | 10.29 | 12.33 | 11.76 | 13.85 | 4.01 | 3.52 | 0.59 | 1.17 |
| EPS in Rs | 20.76 | 3.07 | 0.47 | 9.11 | 4.70 | 7.90 | 9.47 | 9.03 | 10.64 | 3.08 | 2.70 | 0.45 | 0.90 |
Last Updated: August 20, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Fairchem Organics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 131.06 Cr.. The value appears strong and on an upward trend. It has increased from 120.78 Cr. (Mar 2025) to 131.06 Cr., marking an increase of 10.28 Cr..
- For Expenses, as of Jun 2025, the value is 125.83 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.36 Cr. (Mar 2025) to 125.83 Cr., marking an increase of 9.47 Cr..
- For Operating Profit, as of Jun 2025, the value is 5.23 Cr.. The value appears strong and on an upward trend. It has increased from 4.42 Cr. (Mar 2025) to 5.23 Cr., marking an increase of 0.81 Cr..
- For OPM %, as of Jun 2025, the value is 3.99%. The value appears strong and on an upward trend. It has increased from 3.66% (Mar 2025) to 3.99%, marking an increase of 0.33%.
- For Other Income, as of Jun 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.24 Cr. (Mar 2025) to 0.13 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Jun 2025, the value is 1.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.91 Cr. (Mar 2025) to 1.01 Cr., marking an increase of 0.10 Cr..
- For Depreciation, as of Jun 2025, the value is 2.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.64 Cr. (Mar 2025) to 2.74 Cr., marking an increase of 0.10 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.61 Cr.. The value appears strong and on an upward trend. It has increased from 1.11 Cr. (Mar 2025) to 1.61 Cr., marking an increase of 0.50 Cr..
- For Tax %, as of Jun 2025, the value is 27.33%. The value appears to be improving (decreasing) as expected. It has decreased from 46.85% (Mar 2025) to 27.33%, marking a decrease of 19.52%.
- For Net Profit, as of Jun 2025, the value is 1.17 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 1.17 Cr., marking an increase of 0.58 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.90. The value appears strong and on an upward trend. It has increased from 0.45 (Mar 2025) to 0.90, marking an increase of 0.45.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:22 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 306 | 397 | 643 | 648 | 621 | 538 | 504 |
| Expenses | 258 | 328 | 538 | 576 | 554 | 495 | 478 |
| Operating Profit | 49 | 69 | 105 | 72 | 67 | 43 | 26 |
| OPM % | 16% | 17% | 16% | 11% | 11% | 8% | 5% |
| Other Income | 6 | 0 | 0 | 1 | 1 | 1 | 1 |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 | 4 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 | 11 |
| Profit before tax | 42 | 56 | 91 | 59 | 55 | 30 | 13 |
| Tax % | 18% | 24% | 26% | 26% | 26% | 27% | |
| Net Profit | 35 | 42 | 68 | 44 | 40 | 22 | 9 |
| EPS in Rs | 32.62 | 52.15 | 33.41 | 31.10 | 16.87 | 7.13 | |
| Dividend Payout % | 0% | 11% | 25% | 22% | 24% | 44% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 20.00% | 61.90% | -35.29% | -9.09% | -45.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 41.90% | -97.20% | 26.20% | -35.91% |
Fairchem Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -6% |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -31% |
| TTM: | -81% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -26% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 13% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: October 10, 2025, 2:00 pm
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 127 | 156 | 219 | 246 | 277 | 289 |
| Borrowings | 67 | 57 | 62 | 50 | 7 | 63 |
| Other Liabilities | 25 | 33 | 30 | 33 | 37 | 37 |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 |
| Fixed Assets | 126 | 126 | 141 | 156 | 191 | 201 |
| CWIP | 9 | 29 | 42 | 35 | 6 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 83 | 103 | 141 | 151 | 137 | 189 |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 |
Below is a detailed analysis of the balance sheet data for Fairchem Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
- For Reserves, as of Mar 2025, the value is 289.00 Cr.. The value appears strong and on an upward trend. It has increased from 277.00 Cr. (Mar 2024) to 289.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Mar 2025, the value is 63.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 7.00 Cr. (Mar 2024) to 63.00 Cr., marking an increase of 56.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 37.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 37.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 402.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 334.00 Cr. (Mar 2024) to 402.00 Cr., marking an increase of 68.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 191.00 Cr. (Mar 2024) to 201.00 Cr., marking an increase of 10.00 Cr..
- For CWIP, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 6.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 189.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Mar 2024) to 189.00 Cr., marking an increase of 52.00 Cr..
- For Total Assets, as of Mar 2025, the value is 402.00 Cr.. The value appears strong and on an upward trend. It has increased from 334.00 Cr. (Mar 2024) to 402.00 Cr., marking an increase of 68.00 Cr..
Notably, the Reserves (289.00 Cr.) exceed the Borrowings (63.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | 12.00 | 43.00 | 22.00 | 60.00 | -20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 35 | 35 | 33 | 58 |
| Inventory Days | 65 | 64 | 57 | 61 | 57 | 87 |
| Days Payable | 12 | 15 | 7 | 8 | 11 | 8 |
| Cash Conversion Cycle | 98 | 91 | 85 | 89 | 80 | 137 |
| Working Capital Days | 14 | 43 | 40 | 46 | 63 | 68 |
| ROCE % | 30% | 38% | 22% | 19% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| Diluted EPS (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| Cash EPS (Rs.) | 24.97 | 38.23 | 39.67 | 57.63 | 37.68 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 231.96 | 222.67 | 199.11 | 178.29 | 129.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 231.96 | 222.67 | 199.11 | 178.29 | 129.59 |
| Dividend / Share (Rs.) | 7.50 | 7.50 | 7.50 | 13.00 | 3.50 |
| Revenue From Operations / Share (Rs.) | 413.10 | 477.29 | 497.69 | 493.96 | 304.56 |
| PBDIT / Share (Rs.) | 33.88 | 52.31 | 56.07 | 80.81 | 52.96 |
| PBIT / Share (Rs.) | 25.79 | 45.19 | 49.81 | 75.34 | 47.91 |
| PBT / Share (Rs.) | 22.98 | 41.93 | 45.00 | 70.07 | 42.67 |
| Net Profit / Share (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| PBDIT Margin (%) | 8.20 | 10.96 | 11.26 | 16.36 | 17.38 |
| PBIT Margin (%) | 6.24 | 9.46 | 10.00 | 15.25 | 15.73 |
| PBT Margin (%) | 5.56 | 8.78 | 9.04 | 14.18 | 14.01 |
| Net Profit Margin (%) | 4.08 | 6.51 | 6.71 | 10.55 | 10.71 |
| Return on Networth / Equity (%) | 7.27 | 13.96 | 16.77 | 29.25 | 25.17 |
| Return on Capital Employeed (%) | 10.38 | 19.08 | 23.52 | 38.21 | 30.01 |
| Return On Assets (%) | 5.46 | 12.11 | 12.70 | 20.95 | 16.42 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.04 | 0.15 |
| Total Debt / Equity (X) | 0.20 | 0.02 | 0.19 | 0.26 | 0.28 |
| Asset Turnover Ratio (%) | 1.46 | 1.84 | 1.94 | 2.21 | 1.66 |
| Current Ratio (X) | 2.30 | 5.10 | 2.22 | 2.04 | 1.93 |
| Quick Ratio (X) | 1.17 | 2.42 | 1.03 | 0.99 | 1.04 |
| Inventory Turnover Ratio (X) | 6.81 | 8.31 | 6.69 | 8.17 | 6.89 |
| Dividend Payout Ratio (NP) (%) | 44.44 | 24.11 | 38.91 | 6.71 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 30.04 | 19.61 | 32.77 | 6.07 | 0.00 |
| Earning Retention Ratio (%) | 55.56 | 75.89 | 61.09 | 93.29 | 0.00 |
| Cash Earning Retention Ratio (%) | 69.96 | 80.39 | 67.23 | 93.93 | 0.00 |
| Interest Coverage Ratio (X) | 12.03 | 16.07 | 11.66 | 15.35 | 10.11 |
| Interest Coverage Ratio (Post Tax) (X) | 6.99 | 10.55 | 7.95 | 10.91 | 7.23 |
| Enterprise Value (Cr.) | 1202.96 | 1552.81 | 1240.34 | 2021.19 | 1022.58 |
| EV / Net Operating Revenue (X) | 2.24 | 2.50 | 1.91 | 3.14 | 2.58 |
| EV / EBITDA (X) | 27.27 | 22.80 | 16.99 | 19.21 | 14.83 |
| MarketCap / Net Operating Revenue (X) | 2.12 | 2.49 | 1.84 | 3.05 | 2.46 |
| Retention Ratios (%) | 55.55 | 75.88 | 61.08 | 93.28 | 0.00 |
| Price / BV (X) | 3.78 | 5.33 | 4.59 | 8.44 | 5.78 |
| Price / Net Operating Revenue (X) | 2.12 | 2.49 | 1.84 | 3.05 | 2.46 |
| EarningsYield | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Fairchem Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.97. This value is within the healthy range. It has decreased from 38.23 (Mar 24) to 24.97, marking a decrease of 13.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.96. It has increased from 222.67 (Mar 24) to 231.96, marking an increase of 9.29.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.96. It has increased from 222.67 (Mar 24) to 231.96, marking an increase of 9.29.
- For Dividend / Share (Rs.), as of Mar 25, the value is 7.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 7.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 413.10. It has decreased from 477.29 (Mar 24) to 413.10, marking a decrease of 64.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 33.88. This value is within the healthy range. It has decreased from 52.31 (Mar 24) to 33.88, marking a decrease of 18.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 25.79. This value is within the healthy range. It has decreased from 45.19 (Mar 24) to 25.79, marking a decrease of 19.40.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.98. This value is within the healthy range. It has decreased from 41.93 (Mar 24) to 22.98, marking a decrease of 18.95.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For PBDIT Margin (%), as of Mar 25, the value is 8.20. This value is below the healthy minimum of 10. It has decreased from 10.96 (Mar 24) to 8.20, marking a decrease of 2.76.
- For PBIT Margin (%), as of Mar 25, the value is 6.24. This value is below the healthy minimum of 10. It has decreased from 9.46 (Mar 24) to 6.24, marking a decrease of 3.22.
- For PBT Margin (%), as of Mar 25, the value is 5.56. This value is below the healthy minimum of 10. It has decreased from 8.78 (Mar 24) to 5.56, marking a decrease of 3.22.
- For Net Profit Margin (%), as of Mar 25, the value is 4.08. This value is below the healthy minimum of 5. It has decreased from 6.51 (Mar 24) to 4.08, marking a decrease of 2.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.27. This value is below the healthy minimum of 15. It has decreased from 13.96 (Mar 24) to 7.27, marking a decrease of 6.69.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.38. This value is within the healthy range. It has decreased from 19.08 (Mar 24) to 10.38, marking a decrease of 8.70.
- For Return On Assets (%), as of Mar 25, the value is 5.46. This value is within the healthy range. It has decreased from 12.11 (Mar 24) to 5.46, marking a decrease of 6.65.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.20, marking an increase of 0.18.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.46. It has decreased from 1.84 (Mar 24) to 1.46, marking a decrease of 0.38.
- For Current Ratio (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 5.10 (Mar 24) to 2.30, marking a decrease of 2.80.
- For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.42 (Mar 24) to 1.17, marking a decrease of 1.25.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.81. This value is within the healthy range. It has decreased from 8.31 (Mar 24) to 6.81, marking a decrease of 1.50.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 44.44. This value is within the healthy range. It has increased from 24.11 (Mar 24) to 44.44, marking an increase of 20.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 30.04. This value is within the healthy range. It has increased from 19.61 (Mar 24) to 30.04, marking an increase of 10.43.
- For Earning Retention Ratio (%), as of Mar 25, the value is 55.56. This value is within the healthy range. It has decreased from 75.89 (Mar 24) to 55.56, marking a decrease of 20.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 69.96. This value is within the healthy range. It has decreased from 80.39 (Mar 24) to 69.96, marking a decrease of 10.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 12.03. This value is within the healthy range. It has decreased from 16.07 (Mar 24) to 12.03, marking a decrease of 4.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.99. This value is within the healthy range. It has decreased from 10.55 (Mar 24) to 6.99, marking a decrease of 3.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,202.96. It has decreased from 1,552.81 (Mar 24) to 1,202.96, marking a decrease of 349.85.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.24. This value is within the healthy range. It has decreased from 2.50 (Mar 24) to 2.24, marking a decrease of 0.26.
- For EV / EBITDA (X), as of Mar 25, the value is 27.27. This value exceeds the healthy maximum of 15. It has increased from 22.80 (Mar 24) to 27.27, marking an increase of 4.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 2.12, marking a decrease of 0.37.
- For Retention Ratios (%), as of Mar 25, the value is 55.55. This value is within the healthy range. It has decreased from 75.88 (Mar 24) to 55.55, marking a decrease of 20.33.
- For Price / BV (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 3.78, marking a decrease of 1.55.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 2.12, marking a decrease of 0.37.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fairchem Organics Ltd:
- Net Profit Margin: 4.08%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.38% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.27% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.99
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.17
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 104 (Industry average Stock P/E: 402.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.2
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.08%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 253/P & 312, Village Chekhala, Ahmedabad District Gujarat 382115 | cs@fairchem.in http://www.fairchem.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nahoosh Jariwala | Chairman & Managing Director |
| Mr. Sudhin Choksey | Independent Director |
| Mr. Venkatraman Srinivasan | Independent Director |
| Mr. Darius Pandole | Independent Director |
| Ms. Sonal Ambani | Independent Director |
| Mr. Sumit Maheshwari | Nominee Director |
FAQ
What is the intrinsic value of Fairchem Organics Ltd?
Fairchem Organics Ltd's intrinsic value (as of 03 November 2025) is 1464.11 which is 95.21% higher the current market price of 750.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 968 Cr. market cap, FY2025-2026 high/low of 1,308/740, reserves of ₹289 Cr, and liabilities of 402 Cr.
What is the Market Cap of Fairchem Organics Ltd?
The Market Cap of Fairchem Organics Ltd is 968 Cr..
What is the current Stock Price of Fairchem Organics Ltd as on 03 November 2025?
The current stock price of Fairchem Organics Ltd as on 03 November 2025 is 750.
What is the High / Low of Fairchem Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fairchem Organics Ltd stocks is 1,308/740.
What is the Stock P/E of Fairchem Organics Ltd?
The Stock P/E of Fairchem Organics Ltd is 104.
What is the Book Value of Fairchem Organics Ltd?
The Book Value of Fairchem Organics Ltd is 232.
What is the Dividend Yield of Fairchem Organics Ltd?
The Dividend Yield of Fairchem Organics Ltd is 1.00 %.
What is the ROCE of Fairchem Organics Ltd?
The ROCE of Fairchem Organics Ltd is 10.2 %.
What is the ROE of Fairchem Organics Ltd?
The ROE of Fairchem Organics Ltd is 7.51 %.
What is the Face Value of Fairchem Organics Ltd?
The Face Value of Fairchem Organics Ltd is 10.0.